Latest Biotech News

Fujifilm Biotechnologies inaugurated its expanded Teesside campus in the UK, launching what the company calls the largest single-use CDMO facility in Britain after a roughly £400 million ($545...

César de la Fuente’s team at the University of Pennsylvania is training machine-learning models to search genomes for novel antimicrobial peptides, uncovering candidates in archaea, animal venoms,...

A University of California, Irvine-led team developed SIGNET, a machine-learning framework that infers cell-type-specific gene regulatory networks for Alzheimer’s disease and produced what the...

Researchers reported a systematic ligand-diversification screen that couples rapid chemistry with cell-based functional assays to discover molecular glues that induce targeted protein degradation....

Paratus Sciences presented preclinical data for PS-1001, a first-in-class pan-inflammasome inhibitor designed to block release of IL-1β and IL-18, cytokines implicated in autoinflammatory skin...

Nature Biotechnology published a review summarizing recent clinical progress of engineered cellular immunotherapies in autoimmune diseases, highlighting emerging trial data and translational...

Richard Pazdur, the long‑time FDA oncology veteran who stepped down last year, told the Wall Street Journal he was presented with a ready-made quote and asked to "just agree to it" amid agency...

Vinay Prasad, head of the FDA’s Center for Biologics Evaluation and Research, is the subject of internal complaints alleging misconduct while also overruling staff to return a refusal‑to‑file...

The FDA issued a complete response letter to Disc Medicine, rejecting bitopertin for erythropoietic protoporphyria (EPP) and questioning the use of percent change in whole‑blood metal‑free PPIX as...

Fujifilm Biotechnologies inaugurated its expanded Teesside campus in the UK after a roughly £400 million investment, opening what it calls the country's largest single‑use biopharma CDMO facility....

Changchun Genescience Pharmaceutical announced NMPA clearance to initiate clinical trials of Gensci‑136, a dual APRIL/BAFF antagonist for immunoglobulin A nephropathy (IgAN). The NMPA clearance...

A University of California, Irvine team published what they describe as the first cell‑type‑specific gene regulatory network (GRN) map for Alzheimer’s disease, using a machine‑learning framework...

A team led by Georg Winter developed a systematic ligand diversification strategy that generated thousands of chemical variants and screened them in living cells to find molecular glues that...

Nature Biotechnology published a review summarizing the latest clinical advances in engineered cellular immunotherapies for autoimmune diseases. Payne and colleagues synthesize emerging trial data...

CSPC Pharmaceutical Group disclosed that the FDA cleared an investigational new drug (IND) application for SYH‑2082, a long‑acting GLP‑1/GIP receptor dual‑biased agonist peptide for weight...

Researchers from the University of Tokyo developed an AI tool (AI‑IR) that predicts insulin resistance from nine routine clinical measures and applied it to 500,000 UK Biobank participants,...

Researchers at the University of Tokyo applied a machine‑learning predictor for insulin resistance (AI‑IR) to 500,000 UK Biobank participants and found insulin resistance is a statistically...

A team at the University of California, Irvine developed SIGNET, a machine‑learning framework that infers cell‑type–specific gene regulatory networks (GRNs) and applied it to Alzheimer’s disease...

Researchers led by Georg Winter and collaborators used a systematic ligand‑diversification strategy combined with live‑cell functional screening to identify new molecular glues that induce...

Fujifilm Biotechnologies inaugurated an expanded Teesside site in the UK, unveiling what the company calls the largest single‑use biopharmaceutical CDMO facility in the country. Fujifilm Corp....